Skip to content

Use of Local Infiltration Analgesia Following Total Hip Arthroplasty

Local Infiltration Analgesia in Total Hip Arthroplasty - Efficacy of Multiple Bolus Injections With Ropivacaine and Ketorolac

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01344395
Enrollment
80
Registered
2011-04-29
Start date
2010-03-31
Completion date
2011-09-30
Last updated
2013-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Pain, Postoperative

Brief summary

The primary aim of this study is to evaluate if multiple postoperative administrations with a solution of ropivacaine, ketorolac and epinephrine into the operating field through a catheter would affect morphine consumption. Secondary end-points are pain intensity, side effects and length of stay.

Interventions

DRUGropivacaine and ketorolac

The RK-group receives four intra-articular injections via catheter with a total volume of 40 ml (380 mg ropivacaine and 60 mg ketorolac) combined with 4 intravenous injections of saline during 24 hours postoperatively

DRUGKetorolac

The K-group receives four intra-articular injections via catheter with a total volume of 40 ml saline combined with 4 intravenous injections of ketorolac (total 60 mg) during 24 hours postoperatively

Sponsors

Lundbeck Foundation
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for total hip arthroplasty * Patients \> 18 years of age * Signed written informed consent * Spinal anaesthesia

Exclusion criteria

* Allergy towards study drugs * Rheumatoid arthritis * Body Mass Index \> 35 (severe obesity) * Pregnancy or nursing women * Regular opioid use * Patients who can not read or understand danish

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumption24 hours postoperativelyCummulative morphine comsumption postoperatively

Secondary

MeasureTime frameDescription
Pain intensity24 hours postoperativelyPain intensity measured on the visual analog scale (VAS) at rest and during walking
Postoperative nausea24 hours postoperativelyNumber of episodes of nausea measured on a 3 points rating scale (mild, moderate and severe)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026